The California Institute for Regenerative Medicine (CIRM) is proud to join fellow advocates of clinical trial diversity in applauding a new law that will allow the U.S. Food & Drug Administration (FDA) to require diverse representation in clinical trials. A clinical trial, as defined by the FDA, tests potential treatments in human volunteers to see … Continue reading Why diversity in clinical trials is essential
Diversity Equity and Inclusion
Stem Cell Agency Board Approves Funding for Rare Immune Disorder
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Taylor Lookofsky (center), a person with IPEX syndrome, with his father Brian and Dr. Rosa Bacchetta IPEX syndrome is a rare condition where the body can’t control or restrain an immune response, so the person’s immune cells attack their own healthy tissue. The syndrome mostly affects … Continue reading Stem Cell Agency Board Approves Funding for Rare Immune Disorder
A New Model for Diversity in Scientific and Medical Research
Nature Cell Biology cover The global pandemic exposed deep inequities in our health care system and highlighted the need for more diversity in scientific and medical research. The virus hit communities of color the hardest. That in part prompted widespread calls for greater diversity at every level of research. New models for research A recently … Continue reading A New Model for Diversity in Scientific and Medical Research